Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Intraoperative ICG Use During Robotic-Assisted Radical Prostatectomy
NCT06446648Phase 1Recruiting
- Sponsor
- University of California, Irvine
- Start
- Jul 2024
- Primary completion
- Jul 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of indocyanine green in prostate adenocarcinoma (2 arms), sponsored by University of California, Irvine. Primary endpoint: Continence Rate at 3 months. Started Jul 2024; status: recruiting.
02
Drugs
indocyanine green
03
Conditions
prostate adenocarcinoma
Beyond the preview
Go deeper on NCT06446648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06446648.